Several methods for early diagnosis of Alzheimer's disease
(PredictAD)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer's disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.
"The aim of the PredictAD project is to develop an objective indicator to diagnose Alzheimer's disease at the earliest stage possible. Current diagnostic guidelines emphasise the importance of various biomarkers in diagnostics. We have developed novel approaches to extract biomarkers from imaging data, electrophysiological data and blood samples, and a unique and clinically useful software tool for integrating all these heterogeneous measurements." says the Scientific Coordinator of the project, Dr Jyrki Lötjönen from VTT Technical Research Centre of Finland.
Magnetic resonance imaging for identifying atrophy
Detecting changes in the electrophysiology of the brain
Non-invasive techniques to find biomarkers of the disease
Methodology for measuring the state of the patient
Dementia has been recently identified as a health priority both in Europe and in the USA. Alzheimer's disease, the most common cause of dementia, alone accounts for costs equivalent to about 1% of the gross domestic product (GDP) of the whole world and the number of persons affected will double in the next 20 years. Early diagnostics plays a key role in solving the problem because treatments of this irreversible disease should be started in an early phase to be efficient. Various treatments are currently under extensive development. So far, the lack of systematic and objective ways to identify persons for treatments has been apparent. Continue to read: eurekalert.org
Broccoli extract against cancer cells
The safety, and cancer-targeting ability of the broccoli extract sulforaphane, has been backed by a new study finding that it can selectively target cancer cells. Read more: nutraingredients.com
No comments:
Post a Comment